{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:55:55Z","timestamp":1764402955970},"reference-count":34,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.11177","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T09:55:56Z","timestamp":1575366956000},"source":"Crossref","is-referenced-by-count":5,"title":["A retrospective study of autologous stem cell mobilization by G\u2011CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma"],"prefix":"10.3892","author":[{"given":"Gaofeng","family":"Zheng","sequence":"first","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghua","family":"He","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, First Affiliated Hospital, Zhejiang University and First Hospital of Zhejiang Province, Hangzhou, Zhejiang 310001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"key20200714151754_b1-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3109\/07853890.2014.952662","article-title":"Autologous hematopoietic cell transplantation: An update for clinicians","volume":"46","author":"Hamadani","year":"2014","journal-title":"Ann Med"},{"key":"key20200714151754_b2-ol-0-0-11177","first-page":"999","article-title":"Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management","volume":"89","author":"Vincent Rajkumar","year":"2014","journal-title":"Am J Hematol"},{"key":"key20200714151754_b3-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ejh.12362","article-title":"Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: A european perspective","volume":"94","author":"Hubel","year":"2015","journal-title":"Eur J Haematol"},{"key":"key20200714151754_b4-ol-0-0-11177","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"key20200714151754_b5-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0955-3886(99)00043-0","article-title":"The efficiency of PBPC collections and the relationship to the precollection concentration of CD 34+ cells in blood","volume":"20","author":"Gasov\u00e1","year":"1999","journal-title":"Transfus Sci"},{"key":"key20200714151754_b6-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/bmt.2012.281","article-title":"Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: Experience at memorial sloan kettering cancer center","volume":"48","author":"Pozotrigo","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key20200714151754_b7-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1002\/stem.1574","article-title":"Concise review: Sowing the seeds of a fruitful harvest: Hematopoietic stem cell mobilization","volume":"31","author":"Hoggatt","year":"2013","journal-title":"Stem cells"},{"key":"key20200714151754_b8-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20200714151754_b9-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/bmt.2009.370","article-title":"Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma","volume":"45","author":"Gertz","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"key20200714151754_b10-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2141.1994.tb08321.x","article-title":"G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft","volume":"87","author":"Dreger","year":"1994","journal-title":"Br J Haematol"},{"key":"key20200714151754_b11-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/ni813","article-title":"G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4","volume":"3","author":"Petit","year":"2002","journal-title":"Nat Immunol"},{"key":"key20200714151754_b12-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3324\/haematol.2011.056945","article-title":"MicroRNA126 contributes to granulocyte colony-stimulating factor-induced hematopoietic progenitor cell mobilization by reducing the expression of vascular cell adhesion molecule 1","volume":"97","author":"Salvucci","year":"2012","journal-title":"Haematologica"},{"key":"key20200714151754_b13-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/bmt.2012.219","article-title":"Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: Results from the expanded access program","volume":"48","author":"Shaughnessy","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"key20200714151754_b14-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/bmt.2011.133","article-title":"A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor","volume":"47","author":"Abhyankar","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"key20200714151754_b15-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/10428190009113381","article-title":"Characterization and outcome of \u2018hard to mobilize\u2019 lymphoma patients undergoing autologous stem cell transplantation","volume":"39","author":"Sugrue","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"key20200714151754_b16-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/hon.2148","article-title":"PBSC mobilization in lymphoma patients: Analysis of risk factors for collection failure and development of a predictive score based on the kinetics of circulating CD34+ cells and WBC after chemotherapy and G-CSF mobilization","volume":"33","author":"Rossi","year":"2015","journal-title":"Hematol Oncol"},{"key":"key20200714151754_b17-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.clml.2016.04.007","article-title":"Autologous stem cell mobilization in the age of plerixafor","volume":"16","author":"Cooper","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20200714151754_b18-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbmt.2015.11.011","article-title":"Genotype-directed dosing leads to optimized voriconazole levels in pediatric patients receiving hematopoietic stem cell transplantation","volume":"22","author":"Teusink","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20200714151754_b19-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jca.21360","article-title":"Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma","volume":"30","author":"Tuchman","year":"2015","journal-title":"J Clin Apher"},{"key":"key20200714151754_b20-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/trf.12906","article-title":"Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure","volume":"55","author":"Calderon-Cabrera","year":"2015","journal-title":"Transfusion"},{"key":"key20200714151754_b21-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jca.21340","article-title":"Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation","volume":"29","author":"Xia","year":"2014","journal-title":"J Clin Apher"},{"key":"key20200714151754_b22-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/ejh.12266","article-title":"Chemomobilization with high-dose etoposide and G-CSF results in effective and safe stem cell collection in heavily pretreated lymphoma patients: Report from a single institution study and review","volume":"92","author":"Ozkan","year":"2014","journal-title":"Eu J Haematol"},{"key":"key20200714151754_b23-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3324\/haematol.2013.089052","article-title":"Stem cell mobilization in HIV seropositive patients with lymphoma","volume":"98","author":"Re","year":"2013","journal-title":"Haematologica"},{"key":"key20200714151754_b24-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1038\/bcj.2014.79","article-title":"Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients","volume":"4","author":"Clark","year":"2014","journal-title":"Blood Cancer J"},{"key":"key20200714151754_b25-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3109\/14653249.2012.681042","article-title":"Predictive factors for poor peripheral blood stem cell mobilization and peak CD34(+) cell count to guide pre-emptive or immediate rescue mobilization","volume":"14","author":"Sancho","year":"2012","journal-title":"Cytotherapy"},{"key":"key20200714151754_b26-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/vox.12183","article-title":"Incidence and risk factors of poor mobilization in adult autologous peripheral blood stem cell transplantation: A single-centre experience","volume":"107","author":"Lee","year":"2014","journal-title":"Vox Sang"},{"key":"key20200714151754_b27-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/sj.leu.2404801","article-title":"Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma","volume":"21","author":"Kumar","year":"2007","journal-title":"Leukemia"},{"key":"key20200714151754_b28-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2141.2000.02346.x","article-title":"Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile","volume":"111","author":"Watts","year":"2000","journal-title":"Br J Haematol"},{"key":"key20200714151754_b29-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3324\/haematol.2012.071456","article-title":"Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: Results of the prospective PREDICT trial","volume":"98","author":"Russell","year":"2013","journal-title":"Haematologica"},{"key":"key20200714151754_b30-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/bmt.2010.54","article-title":"Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data","volume":"46","author":"Duarte","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"key20200714151754_b31-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.leukres.2010.12.036","article-title":"Plerixafor and G-CSF for PBSC mobilization in patients with lymphoma who failed previous attempts with G-CSF and chemotherapy: A REL (Rete Ematologica Lombarda) experience","volume":"35","author":"Arcaini","year":"2011","journal-title":"Leukemia Res"},{"key":"key20200714151754_b32-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2165\/11206040-000000000-00000","article-title":"Plerixafor: A review of its use in stem-cell mobilization in patients with lymphoma or multiple myeloma","volume":"71","author":"Keating","year":"2011","journal-title":"Drugs"},{"key":"key20200714151754_b33-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.transci.2004.09.008","article-title":"Factors for PBPC collection efficiency and collection predictors","volume":"31","author":"Ikeda","year":"2004","journal-title":"Transfus Apher Sci"},{"key":"key20200714151754_b34-ol-0-0-11177","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s002770100351","article-title":"Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma","volume":"80","author":"Perea","year":"2001","journal-title":"Annals Hematol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T14:22:24Z","timestamp":1594736544000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.11177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.11177","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}